India’s top drug advisory body recommends restricting over-the-counter access to most nicotine replacement therapies, sparking concerns that it will hinder smokers’ efforts to quit. While tobacco products remain widely available, this move could create more hurdles for those seeking quitting aids, potentially impacting public health initiatives. NEW DELHI: Access to quitting aids like nicotine gums…